Home
Sage Therapeutics, Inc.

Sage Therapeutics, Inc. Market Share Analysis for May 2026

sage therapeutics is a biopharmaceutical company developing novel therapies for brain health disorders with depression, neurology and neuropsychiatric franchise programs.

Health > Biotechnology and Pharmaceuticals

Domainsagerx.com

Year Founded2010

Employees201 - 500

Annual Revenue> $1B

Sage Therapeutics, Inc.

Sage Therapeutics, Inc. (including company regionals)

sagerx.com

See more website traffic and engagement information

Sage Therapeutics, Inc. Revenue up to May 2026 is > 1B

revenue generated by Sage Therapeutics, Inc. top domains

Sage Therapeutics, Inc. top domains revenue over 3 years

Revenue for Sage Therapeutics, Inc. top domains

sagerx.com> 1B

See more with Sales Intelligence

Total visits to Sage Therapeutics, Inc.'s top domains

Understand Sage Therapeutics, Inc. market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

sagerx.com3.3K

See more with Sales Intelligence

Avg. visit duration in Sage Therapeutics, Inc.'s top domains

Analyze Sage Therapeutics, Inc. engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

sagerx.com00:01:11

See more with Sales Intelligence

Avg. pageviews on Sage Therapeutics, Inc.'s top domains

See how Sage Therapeutics, Inc. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

sagerx.com2.67

See more with Sales Intelligence

Sage Therapeutics, Inc. top competitors by domain

Top similar sites in May 2026, ranked by their affinity

alector.comCompany NameAlectorEmployees51 - 200HQUnited States, California, South San FranciscoAnnual revenue$100M - $200MTotal visits6.2KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Sage Therapeutics, Inc.

These are the website technologies, by industry, used by Sage Therapeutics, Inc. top domains

Payment & Currencies (8)

Cart Functionality

Advertising (5)

AppNexus

Widget (4)

reCAPTCHA

Content Management System (2)

WordPress

More Technologies

10

See all

News & Signals from Sage Therapeutics, Inc.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsMike left Sage Therapeutics, Inc. as Chief Scientific Officer and interim Head of R&D on Jun 11th '26.Most recently, Mike served as Chief Scientific Officer and interim Head of R&D at Sage Therapeutics (Sage) where he worked on the first medicines approved for the treatment of Postpartum Depression and helped to build a portfolio targeting a range of brain health conditions with a specific interest in indications at the intersection of neuroscience and women's health.

NewsSage Therapeutics, Inc. decreased headcount by 338 on Aug 1st '25.Two weeks later, on June 26, Sage filed a WARN with Massachusetts indicating they were laying off all 338 employees in August pending deal closure.

NewsSage Therapeutics, Inc. is developing zuranolone .It's an anticlimactic end for Sage, which had partnered with Biogen to develop a drug called zuranolone - marketed as Zurzuvae - for postpartum depression as well as major depressive disorder (MDD).